COMPOSITIONS COMPRISING RECOMBINANT STRAINS OF MYCOBACTERIUM, USES THEREOF AND METHODS FOR THE PREVENTION AND/OR TREATMENT OF CANCER

The present invention relates to the use of recombinant Mycobacterium strains encoding the A subunit of the heat-labile LT toxin from mutated Escherichia coli, in the manufacture of an immunobiological composition for the prevention and/or treatment of cancer in animals. Preferably, the mutation is...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: TRENTINI, Monalisa Martins, MORENO, Ana Carolina Ramos, LEITE, Luciana Cezar de Cerqueira, SOTO, Dunia Del Carmen Rodriguez
Format: Patent
Sprache:eng ; fre ; por
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention relates to the use of recombinant Mycobacterium strains encoding the A subunit of the heat-labile LT toxin from mutated Escherichia coli, in the manufacture of an immunobiological composition for the prevention and/or treatment of cancer in animals. Preferably, the mutation is at position 63 from serine to lysine. The present invention also provides immunobiological compositions comprising said strains for use in the prevention and / or treatment of cancer. Finally, the present invention relates to methods for the prevention and / or treatment of cancer, comprising the administration of said strains to an individual in need thereof. In particular, said cancer is bladder cancer. La présente invention concerne l'utilisation de souches de Mycobacterium recombinantes qui codent pour la sous-unité A de la toxine thermolabile LT d'Escherichia coli mutée, dans la fabrication d'une composition immunologique pour prévenir et/ou traiter le cancer chez des animaux. De préférence, la mutation se produit en position 63 de la sérine pour la lysine. La présente invention concerne également des compositions immunobiologiques comprenant lesdites souches en vue de leur utilisation dans la prévention et/ou le traitement du cancer. Enfin, la présente invention concerne des méthodes pour la prévention et/ou le traitement de cancer comprenant l'administration desdites couches à un individu les nécessitant. En particulier, ledit cancer est le cancer de la vessie. A presente invenção refere-se ao uso de cepas de Mycobacterium recombinantes que codificam a subunidade A da toxina termo-lábil LT de Escherichia coli mutada, na fabricação de uma composição imunobiológica para prevenir e/ou tratar câncer em animais. Preferencialmente, a mutação é na posição 63 de serina para lisina. A presente invenção fornece também composições imunobiológicas compreendendo as referidas cepas para uso na prevenção e/ou tratamento de câncer. Por último, a presente invenção refere-se a métodos para prevenção e/ou tratamento de câncer, compreendendo a administração das referidas cepas a um indivíduo em necessidade das mesmas. Em particular, o referido câncer é câncer de bexiga.